GenMark Diagnostics, Inc. (GNMK): Price and Financial Metrics
GNMK Stock Summary
- The price/operating cash flow metric for GenMark Diagnostics Inc is higher than 97.72% of stocks in our set with a positive cash flow.
- GNMK's price/sales ratio is 8.07; that's higher than the P/S ratio of 78.62% of US stocks.
- Revenue growth over the past 12 months for GenMark Diagnostics Inc comes in at 94.9%, a number that bests 94.34% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to GenMark Diagnostics Inc are RDFN, TRXC, DYAI, GKOS, and PSTG.
- Visit GNMK's SEC page to see the company's official filings. To visit the company's web site, go to www.genmarkdx.com.
GNMK Stock Price Chart Interactive Chart >
GNMK Price/Volume Stats
|Current price||$18.95||52-week high||$23.59|
|Prev. close||$18.94||52-week low||$3.37|
|Day high||$19.34||Avg. volume||1,251,316|
|50-day MA||$16.44||Dividend yield||N/A|
|200-day MA||$14.30||Market Cap||1.38B|
GenMark Diagnostics, Inc. (GNMK) Company Bio
GenMark Diagnostics, Inc. develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company is based in Carlsbad, California.
GNMK Latest News Stream
|Loading, please wait...|
GNMK Latest Social Stream
View Full GNMK Social Stream
Latest GNMK News From Around the Web
Below are the latest news stories about GenMark Diagnostics Inc that investors may wish to consider to help them evaluate GNMK as an investment opportunity.
GenMark Diagnostics, Inc. (GNMK) Q4 2020 Earnings Conference Call February 25, 2021 04:30 PM ET Company Participants Leigh Salvo - Investor Relations, Gilmartin Group LLC Scott Mendel - President & Chief Executive Officer Johnny Ek - Chief Financial Officer Conference Call Participants Chris Shibutani - Cowen Stephanie Yan - Canaccord...
Canaccord Genuity Stick to Their Buy Rating for Genmark Diagnostics
GenMark Diagnostics Earnings Report: Here’s what to expect from Stock market Insights & financial analysis
GenMark Diagnostics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that its ePlex Respiratory Pathogen Panel 2 (RP2) is predicted to detect known SARS-CoV-2 variants currently in circulation. As the COVID-19 pandemic continues to evolve, GenMark is routinely monitoring publicly available databases for new SARS-CoV-2 strains and variants and conducting bioinformatic analyses to determine if the mutations present in the viral genome would impact detection of these variants on the ePlex RP2 Panel. The recently identified SARS-CoV-2 variant strains include multiple mutations with the majority occurring in the spike protein, or S gene region and additional mutations fou...
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference. GenMark’s management team is scheduled to present in a virtual setting on Monday, March 1st, 2021 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com ABOUT GENMARKGenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s e...
GNMK Price Returns
Continue Researching GNMKWant to see what other sources are saying about GenMark Diagnostics Inc's financials and stock price? Try the links below:
GenMark Diagnostics Inc (GNMK) Stock Price | Nasdaq
GenMark Diagnostics Inc (GNMK) Stock Quote, History and News - Yahoo Finance
GenMark Diagnostics Inc (GNMK) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!